Analyst Coverage
| Firm | Analyst |
|---|---|
| Deutsche Bank | David M. Steinberg |
| Ladenberg Thalmann | Geoffrey O'Brien |
| Merrill Lynch | Gregg Gilbert |
| Morgan Stanley | Steven Harr, M.D. |
MAP Pharmaceuticals, Inc. is followed by the analyst(s) listed above. Please note that any opinions, estimates or forecasts regarding MAP Pharmaceuticals, Inc.'s performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of MAP Pharmaceuticals, Inc. or its management. MAP Pharmaceuticals, Inc. does not by its reference above or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations.
Stock Information
| NASD:MAPP
$9.95 |
- 0.50 |
| Aug 28, 2008 | 1:43 PM ET |
Quotes delayed at least 20 minutes.
Information provided by TurboFeed.
Information provided by TurboFeed.

